Scarless Therapeutics
Company

Scarless Therapeutics

Biotechnology Research Tehran, Ir 3 employees
Employees
3

Scarless Therapeutics Overview

Headquarters
Tehran, Ir
Website
scarlesstx.com
Industry
Biotechnology Research
Employees
3
Founded
2024
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Scarless Therapeutics

At Scarless Therapeutics (ScarlessTx), we are pioneering the future of medicine by seamlessly integrating cutting-edge technologies like genome editing, mRNA, and artificial intelligence (AI) to develop revolutionary therapies. Our mission is to redefine healthcare through precision medicine, offering personalized solutions that address the root causes of diseases with unmatched accuracy and efficiency. Harnessing the power of CRISPR-Cas9 gene-editing technology, we are advancing groundbreaking treatments such as our personalized cancer vaccine, designed to empower the immune system to target and eliminate cancer cells with unprecedented precision. By combining CRISPR-Cas9 with advanced AI-driven neoantigen prediction and mRNA delivery systems, we create highly tailored therapies that are as unique as the patients we serve. At ScarlessTx, innovation is at the heart of everything we do. From our ex vivo gene-edited therapies to our next-generation cancer vaccines, we are committed to pushing the boundaries of science to deliver transformative treatments. Our vision is a world where diseases are not just managed but cured, and where every patient has access to personalized, life-changing therapies. Join us as we lead the way in the New Era of Genetic Medicine—where gene editing, mRNA technology, and AI converge to create a scarless future for healthcare. Together, we are shaping a healthier, brighter tomorrow.

Scarless Therapeutics Contact Details

People in AeroLeads
2

Scarless Therapeutics Org Chart

Sample employees and titles
Name Title Contact
S.reza Mahmoudi Chief Financial Officer at Scarless
View
Amin Ghahremani Co-founder and CTO at Scarless
View

Compare Similar Companies to Scarless Therapeutics